Browsed by
Tag: AIDS

Sing for Life 2012

Sing for Life 2012

  • sing-for-lifeon Sat. 1st Dec 2012
  • at 8pm
  • Eglise Saint-Boniface, Ixelles-Elsene

Three Brussels choirs combine their talent in a unique benefit concert: Sing for Life!

If you cannot go to the Swim for Life, please find below another opportunity to support the fight against AIDS.

  1. Tapalanote, the choir of BGS, will draw from a repertoire of pop and chanson française.
  2. Le Petit Sablon will bring a classical touch to the evening; whilst
  3. Anaconda, the latin-American choir of Brussels, will heat up the atmosphere with their swinging rhythms.

The money will help support concrete projects to prevent AIDS.

Since its inception, Swim For Life has raised €323,000.

  • When: Saturday 1 December 2012 at 8pm (doors open 7.30pm)
  • Where: Eglise Saint Boniface, Rue de la Paix, 21A-23, 1050 Ixelles
  • Price: €8 advanced booking, €10 on the door.
  • Order tickets in advance at Tickets on sale
    or by email choir@bgs.org

If you found an error, highlight it and press Shift + Enter or click here to inform us.

HIV Vaccine Safe Enough To Pass Phase 1 Human Trials

HIV Vaccine Safe Enough To Pass Phase 1 Human Trials

With interim results, the SAV001-H has proven safety and tolerability in humans and given confidence for the next clinical trials to prove its immunogenicity and efficacy evaluation.

The first human applied clinical study (SAV CT 01) using a genetically modified killed whole-virus vaccine (SAV001-H) to evaluate its safety and tolerability was initiated in March 2012. Infected men and women, 18-50 years of age, have been enrolled in this study and randomized into two treatment groups to administer killed whole HIV-1 vaccine (SAV001-H) or placebo.

Read complete article at Slashdot

If you found an error, highlight it and press Shift + Enter or click here to inform us.

HIV Vaccine Approval For Human Trials

HIV Vaccine Approval For Human Trials

Researchers from the University of Western Ontario have been given approval from the U.S. Food and Drug Administration to begin testing an HIV vaccine in humans.

“The vaccine is the first based on a genetically modified killed whole virus, [researchers said.] … a clinical trial on 40 HIV-positive volunteers will begin next month. That phase will last a year, after which 600 HIV-negative volunteers will see how the vaccine impacts their immune systems. A final phase, which will take about three years, will involve about 6,000 HIV-negative volunteers.”

from Slashdot (Soulskill on Tuesday December 20, @05:18PM)

If you found an error, highlight it and press Shift + Enter or click here to inform us.